AGXT and hereditary sensory and autonomic neuropathy type 1: Mammalian cells exhibited a loss of viability, with a partial loss of SPT function resulting in a rare SL metabolic disease, Hereditary Sensory Neuropathy type I (HSN1) (Hanada, 2003).